Does Wegovy Cause Constipation? An Endocrinologist Explains

Constipation is one of the most common side effects reported by patients taking Wegovy (semaglutide), a GLP-1 receptor agonist approved for chronic weight management. While Wegovy has transformed obesity treatment, its effects on the digestive system—including slowed gastric emptying—can lead to uncomfortable constipation. Understanding why this happens, how to manage it, and when to seek medical advice can help patients stay on track with their weight loss journey without unnecessary discomfort.

Why Does Wegovy Cause Constipation?

Wegovy (semaglutide) mimics the action of glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite, insulin secretion, and gastrointestinal motility. One of the primary mechanisms by which Wegovy promotes weight loss is by slowing gastric emptying—the process by which food moves from the stomach into the small intestine. While this delay enhances satiety and reduces calorie intake, it also slows the transit of stool through the digestive tract, leading to harder, drier stools and constipation.

Additionally, GLP-1 receptor agonists like Wegovy may reduce intestinal secretions, further contributing to constipation. Studies suggest that semaglutide’s effect on gut motility is dose-dependent, meaning higher doses of Wegovy may increase the likelihood of constipation. Dehydration, a common issue in patients adjusting to Wegovy’s appetite-suppressing effects, can also exacerbate constipation by making stools harder to pass.

How Common Is Constipation on Wegovy?

Constipation is a well-documented side effect of Wegovy, with clinical trials providing clear evidence of its prevalence. In the STEP trials, which evaluated Wegovy for weight loss, constipation was reported in approximately 15-20% of participants, making it one of the most frequent gastrointestinal side effects. For comparison, nausea—a widely recognized side effect of GLP-1 medications—occurred in about 40% of patients, while constipation was the second most common digestive complaint.

The incidence of constipation on Wegovy appears to be higher than with some other GLP-1 receptor agonists, such as liraglutide (Saxenda), where constipation rates were closer to 10-12%. This difference may be attributed to Wegovy’s longer half-life and more potent effects on gastric emptying. Women and older adults may be particularly susceptible to Wegovy-induced constipation due to hormonal influences and age-related changes in gut motility.

How Long Does Wegovy Constipation Last?

For most patients, constipation caused by Wegovy is temporary and improves as the body adjusts to the medication. In clinical trials, gastrointestinal side effects, including constipation, were most pronounced during the dose-escalation phase (the first 16 weeks of treatment) when patients gradually increase their Wegovy dosage. Many patients report that constipation peaks at the 1.7 mg and 2.4 mg doses but begins to subside after 4-8 weeks at the maintenance dose.

However, some patients may experience persistent constipation throughout their treatment with Wegovy. Factors such as dehydration, low dietary fiber intake, and pre-existing gastrointestinal conditions (e.g., irritable bowel syndrome) can prolong symptoms. If constipation does not improve after 3-4 months on a stable dose of Wegovy, patients should discuss management strategies with their healthcare provider, as chronic constipation can lead to complications like hemorrhoids or fecal impaction.

How to Manage Constipation While Taking Wegovy

Managing constipation on Wegovy requires a multifaceted approach that addresses hydration, diet, physical activity, and, if necessary, medication. Here are evidence-based strategies to alleviate symptoms:

1. Increase Fluid Intake: Dehydration worsens constipation, so aim for at least 2-3 liters of water daily. Herbal teas and broths can also help. Avoid excessive caffeine or alcohol, as they can contribute to dehydration.

2. Prioritize Dietary Fiber: Soluble fiber (found in oats, apples, beans, and flaxseeds) softens stools, while insoluble fiber (found in whole grains, vegetables, and nuts) adds bulk. Gradually increase fiber intake to 25-35 grams per day to avoid bloating. Psyllium husk (e.g., Metamucil) is a well-tolerated fiber supplement that can be particularly effective for Wegovy-induced constipation.

3. Exercise Regularly: Physical activity stimulates intestinal contractions. Even 20-30 minutes of walking daily can improve gut motility. Yoga poses like the “wind-relieving pose” (Pavanamuktasana) may also help.

4. Establish a Routine: Try to have a bowel movement at the same time each day, preferably after a meal when gut motility is naturally increased. Don’t ignore the urge to go, as this can worsen constipation.

5. Over-the-Counter Remedies: If lifestyle changes are insufficient, consider short-term use of:

   • Osmotic laxatives (e.g., polyethylene glycol/Miralax): Draw water into the intestines to soften stools.
   • Stool softeners (e.g., docusate sodium/Colace): Help stools retain moisture.
   • Stimulant laxatives (e.g., bisacodyl/Dulcolax or senna): Stimulate intestinal contractions but should be used sparingly to avoid dependence.

6. Probiotics: Emerging evidence suggests that probiotics, particularly strains like Bifidobacterium lactis and Lactobacillus acidophilus, may improve gut motility and alleviate constipation. Fermented foods (e.g., yogurt, kefir, sauerkraut) or supplements can be beneficial.

7. Adjust Wegovy Timing: Some patients find that taking Wegovy in the evening reduces constipation, as the medication’s peak effects on gastric emptying occur during sleep rather than after meals.

When to See Your Doctor About Wegovy and Constipation

While constipation is a common and often manageable side effect of Wegovy, there are situations where medical evaluation is warranted. Contact your healthcare provider if you experience any of the following:

• No bowel movement for 3+ days despite using laxatives or dietary changes.
• Severe abdominal pain, bloating, or vomiting, which could indicate a bowel obstruction (a rare but serious complication of chronic constipation).
• Blood in your stool or black, tarry stools, which may signal hemorrhoids, anal fissures, or gastrointestinal bleeding.
• Unexplained weight loss or fever, which could suggest an underlying condition like inflammatory bowel disease.
• Constipation that persists for more than 3 months despite treatment, as this may require further evaluation (e.g., thyroid function tests, colonoscopy) to rule out other causes.

Your doctor may recommend adjusting your Wegovy dosage, switching to a different GLP-1 medication (e.g., tirzepatide/Mounjaro, which has a lower reported incidence of constipation), or referring you to a gastroenterologist for specialized care. In some cases, a short-term “drug holiday” from Wegovy may be considered to allow the digestive system to reset.

Wegovy Constipation vs Other GLP-1 Side Effects

Constipation is just one of several gastrointestinal side effects associated with Wegovy and other GLP-1 receptor agonists. Understanding how it compares to other common side effects can help patients anticipate and manage their symptoms effectively.

• Nausea: The most frequent side effect of Wegovy, affecting ~40% of patients, nausea typically occurs during the dose-escalation phase and improves over time. Unlike constipation, which results from slowed gut motility, nausea is thought to stem from delayed gastric emptying and central nervous system effects. Eating smaller, bland meals and avoiding fatty or spicy foods can help.

• Diarrhea: Reported in ~10-15% of Wegovy users, diarrhea is less common than constipation but can occur due to changes in gut microbiota or rapid transit of stool through the intestines. Staying hydrated and avoiding high-fiber foods during episodes can help.

• Vomiting: Occurs in ~5-10% of patients, often alongside nausea. Vomiting is more likely at higher doses of Wegovy and may require dose reduction or anti-nausea medications (e.g., ondansetron).

• Abdominal Pain/Bloating: Affects ~10-15% of users, abdominal discomfort may result from gas buildup due to slowed digestion. Over-the-counter simethicone (Gas-X) or peppermint oil capsules may provide relief.

• Acid Reflux/Heartburn: Wegovy can relax the lower esophageal sphincter, leading to gastroesophageal reflux disease (GERD) in some patients. Elevating the head of the bed, avoiding late-night meals, and taking antacids (e.g., famotidine/Pepcid) can help.

Unlike nausea and vomiting, which often resolve within weeks, constipation may persist for months in some patients. However, with proactive management, most patients can continue Wegovy without significant disruption to their daily lives.

Does Wegovy Dosage Affect Constipation?

The relationship between Wegovy dosage and constipation is dose-dependent, meaning higher doses are more likely to cause or worsen symptoms. Wegovy is administered via a gradual dose-escalation schedule to minimize side effects, starting at 0.25 mg weekly and increasing every 4 weeks to a maintenance dose of 2.4 mg weekly. Constipation typically becomes more noticeable at the 1.7 mg and 2.4 mg doses, as these higher levels of semaglutide exert a stronger effect on gastric emptying and gut motility.

In clinical trials, the incidence of constipation increased with each dose escalation:

• 0.25 mg: ~5% of patients reported constipation.
• 0.5 mg: ~8%.
• 1.0 mg: ~12%.
• 1.7 mg: ~15%.
• 2.4 mg: ~20%.

For patients who experience severe or persistent constipation at higher doses of Wegovy, healthcare providers may consider:

1. Extending the dose-escalation period: Slowing the rate of increase (e.g., staying at 1.7 mg for 6-8 weeks instead of 4) can help the body adapt.
2. Reducing the maintenance dose: Some patients tolerate 1.7 mg weekly as their long-term dose, which may be sufficient for weight loss while minimizing side effects.
3. Splitting the dose: Dividing the weekly dose into two injections (e.g., 1.2 mg twice weekly) may reduce peak drug levels and associated side effects, though this is an off-label approach.

Patients should never adjust their Wegovy dosage without medical supervision, as improper dosing can compromise weight loss results or lead to withdrawal-like symptoms (e.g., increased appetite, nausea).

Frequently Asked Questions

Does Wegovy cause constipation in everyone?

No, Wegovy does not cause constipation in every patient. Approximately 15-20% of users experience constipation, with risk factors including dehydration, low fiber intake, sedentary lifestyle, and higher doses of the medication. Some patients may not notice any digestive changes while taking Wegovy.

How long does constipation last on Wegovy?

Constipation on Wegovy is often temporary, peaking during the dose-escalation phase (first 16 weeks) and improving within 4-8 weeks at the maintenance dose. However, some patients may experience persistent constipation, particularly if they have pre-existing gastrointestinal issues or poor hydration habits.

Can you prevent constipation on Wegovy?

While constipation cannot always be prevented, proactive measures can significantly reduce its severity. These include increasing water intake, consuming 25-35 grams of fiber daily, exercising regularly, and establishing a consistent bowel routine. Starting fiber supplements (e.g., psyllium husk) at the beginning of Wegovy treatment may also help.

Is constipation a reason to stop taking Wegovy?

Constipation alone is rarely a reason to discontinue Wegovy, as it is usually manageable with lifestyle changes and over-the-counter remedies. However, if constipation is severe, persistent, or accompanied by concerning symptoms (e.g., abdominal pain, vomiting, or blood in stool), patients should consult their doctor to discuss dose adjustments or alternative treatments.

Disclaimer from Dr. Nina Patel: The information provided in this article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before making changes to your medication regimen or managing side effects. Individual responses to Wegovy (semaglutide) may vary, and your doctor can provide personalized guidance based on your health history and needs.